{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:22:59Z","timestamp":1790461379018,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.099","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T11:38:43Z","timestamp":1317987523000},"page":"8838-8846","source":"Crossref","is-referenced-by-count":28,"title":["Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Imran","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsaf","family":"Hedhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Moir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josette","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Debierre-Grockiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dimier-Poisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie No\u00eblle","family":"M\u00e9v\u00e9lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.09.099_bib0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.09.099_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0020-7519(01)00354-X","article-title":"Recent advances in the search for new anti-coccidial drugs","volume":"32","author":"Coombs","year":"2002","journal-title":"Int J Parasitol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2011.09.099_bib0015","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1017\/S0031182006001855","article-title":"Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora","volume":"133","author":"Innes","year":"2006","journal-title":"Parasitology"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2011.09.099_bib0025","doi-asserted-by":"crossref","first-page":"632424","DOI":"10.1155\/2008\/632424","article-title":"Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis","volume":"2008","author":"Dlugonska","year":"2008","journal-title":"J Biomed Biotechnol"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.09.099_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","article-title":"Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis","volume":"123","author":"Dziadek","year":"2009","journal-title":"Exp Parasitol"},{"issue":"September (38)","key":"10.1016\/j.vaccine.2011.09.099_bib0240","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"issue":"May (3\u20134)","key":"10.1016\/j.vaccine.2011.09.099_bib0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vetpar.2005.01.006","article-title":"Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii","volume":"129","author":"Garcia","year":"2005","journal-title":"Vet Parasitol"},{"issue":"April (3\u20134)","key":"10.1016\/j.vaccine.2011.09.099_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetpar.2007.01.007","article-title":"Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route","volume":"145","author":"Garcia","year":"2007","journal-title":"Vet Parasitol"},{"issue":"October (40)","key":"10.1016\/j.vaccine.2011.09.099_bib0050","doi-asserted-by":"crossref","first-page":"34245","DOI":"10.1074\/jbc.M504158200","article-title":"Proteomic analysis of rhoptry organelles reveals many novel constituents for host\u2013parasite interactions in Toxoplasma gondii","volume":"280","author":"Bradley","year":"2005","journal-title":"J Biol Chem"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0055","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.ppat.0010017","article-title":"Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles","volume":"1","author":"Alexander","year":"2005","journal-title":"PLoS Pathog"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0060","doi-asserted-by":"crossref","first-page":"e1000309","DOI":"10.1371\/journal.ppat.1000309","article-title":"Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion","volume":"5","author":"Besteiro","year":"2009","journal-title":"PLoS Pathog"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0065","doi-asserted-by":"crossref","first-page":"e1001276","DOI":"10.1371\/journal.ppat.1001276","article-title":"The RON2\u2013AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites","volume":"7","author":"Lamarque","year":"2011","journal-title":"PLoS Pathog"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","article-title":"Apical membrane antigen 1: a malaria vaccine candidate in review","volume":"24","author":"Remarque","year":"2008","journal-title":"Trends Parasitol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.09.099_bib0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.exppara.2007.01.017","article-title":"Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential","volume":"116","author":"Dautu","year":"2007","journal-title":"Exp Parasitol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.09.099_bib0080","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/IAI.01717-07","article-title":"Identification and characterization of the Plasmodium yoelii PyP140\/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection","volume":"76","author":"Narum","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.099_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.vaccine.2011.09.099_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"August (36)","key":"10.1016\/j.vaccine.2011.09.099_bib0095","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","article-title":"Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice","volume":"23","author":"Mevelec","year":"2005","journal-title":"Vaccine"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2011.09.099_bib0100","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2009.02.107","article-title":"Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection","volume":"27","author":"Ismael","year":"2009","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.09.099_bib0105","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/IAI.69.3.1605-1612.2001","article-title":"Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii","volume":"69","author":"Bonenfant","year":"2001","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/IAI.68.2.969-972.2000","article-title":"Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments","volume":"68","author":"Velge-Roussel","year":"2000","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.09.099_bib0115","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1462-5822.2005.00646.x","article-title":"The rhoptry neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion","volume":"7","author":"Lebrun","year":"2005","journal-title":"Cell Microbiol"},{"issue":"May\u2013June (1\u20132)","key":"10.1016\/j.vaccine.2011.09.099_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-4894(03)00115-2","article-title":"Expression of functional hypodermin A, a serine protease from Hypoderma lineatum (Diptera, Oestridae), in Schneider 2 cells","volume":"104","author":"Khaznadji","year":"2003","journal-title":"Exp Parasitol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-6851(91)90092-K","article-title":"Characterization of the protein contents of rhoptries and dense granules of Toxoplasma gondii tachyzoites by subcellular fractionation and monoclonal antibodies","volume":"45","author":"Leriche","year":"1991","journal-title":"Mol Biochem Parasitol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.09.099_bib0130","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/IAI.71.11.6222-6228.2003","article-title":"The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis","volume":"71","author":"Ismael","year":"2003","journal-title":"Infect Immun"},{"issue":"November (50)","key":"10.1016\/j.vaccine.2011.09.099_bib0135","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1016\/j.vaccine.2010.09.084","article-title":"Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines","volume":"28","author":"Qin","year":"2010","journal-title":"Vaccine"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2011.09.099_bib0140","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/nar\/27.19.3792","article-title":"size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency","volume":"27","author":"Kreiss","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.09.099_bib0145","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: supercoiled minicircle","volume":"4","author":"Darquet","year":"1997","journal-title":"Gene Ther"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.09.099_bib0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ab.2005.08.029","article-title":"Investigations of the effect of DNA size in transient transfection assay using dual luciferase system","volume":"346","author":"Yin","year":"2005","journal-title":"Anal Biochem"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.09.099_bib0155","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jps.20879","article-title":"Design of PCR-amplified DNA fragments for in vivo gene delivery: size-dependency on stability and transgene expression","volume":"96","author":"Hirata","year":"2007","journal-title":"J Pharm Sci"},{"issue":"June (5\u20136)","key":"10.1016\/j.vaccine.2011.09.099_bib0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s001090100227","article-title":"Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide","volume":"79","author":"Schirmbeck","year":"2001","journal-title":"J Mol Med (Berl)"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.099_bib0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunol Rev"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.09.099_bib0170","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.09.099_bib0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","article-title":"Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach","volume":"62","author":"Buus","year":"2003","journal-title":"Tissue Antigens"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.09.099_bib0180","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.09.099_bib0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.exppara.2007.10.002","article-title":"Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB\/c mice","volume":"118","author":"Igarashi","year":"2008","journal-title":"Exp Parasitol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.09.099_bib0190","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.09.099_bib0195","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii","volume":"68","author":"Sayles","year":"2000","journal-title":"Infect Immun"},{"issue":"September (90)","key":"10.1016\/j.vaccine.2011.09.099_bib0200","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","article-title":"Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice","volume":"66","author":"Letscher-Bru","year":"1998","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.099_bib0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/IAI.68.1.38-45.2000","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice","volume":"68","author":"Vercammen","year":"2000","journal-title":"Infect Immun"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2011.09.099_bib0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis","volume":"11","author":"Martin","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.09.099_bib0215","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exppara.2005.11.009","article-title":"Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts","volume":"112","author":"Nielsen","year":"2006","journal-title":"Exp Parasitol"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.09.099_bib0220","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.vaccine.2006.02.039","article-title":"Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein","volume":"24","author":"Echeverria","year":"2006","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.09.099_bib0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-3024.2007.00961.x","article-title":"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii","volume":"29","author":"Jongert","year":"2007","journal-title":"Parasite Immunol"},{"issue":"September (39)","key":"10.1016\/j.vaccine.2011.09.099_bib0230","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1016\/j.vaccine.2008.07.031","article-title":"Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis","volume":"26","author":"Cuppari","year":"2008","journal-title":"Vaccine"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2011.09.099_bib0235","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.vaccine.2009.01.100","article-title":"Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant","volume":"27","author":"Hedhli","year":"2009","journal-title":"Vaccine"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.09.099_bib0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.exppara.2011.04.004","article-title":"Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection","volume":"128","author":"Sanchez","year":"2011","journal-title":"Exp Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T17:53:19Z","timestamp":1593107599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":48,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11015416"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}